Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phasesYe Guo, Jin Li, Yueyin Pan et al.|European Journal of Cancer|2022Cited by 57
Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 studyFeng Bi, Jiayuan Wu, Shukui Qin et al.|European journal of medical research|2025Cited by 1